Selected research
Market Outlook & Growth Opportunities
Global Nutraceutical Gummies Market Outlook and Growth Opportunities 2026
Market perspective
The global Nutraceutical Gummies market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Nutraceutical Gummies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Nutraceutical Gummies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Nutraceutical Gummies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Nutraceutical Gummies market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Nutraceutical Gummies market include Church & Dwight (CHD), SCN BestCo, Amapharm, Sirio, Guangdong Yichao, Aland, Herbaland, Jinjiang Qifeng and TopGum, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Nutraceutical Gummies market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Nutraceutical Gummies and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Nutraceutical Gummies sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nutraceutical Gummies market size, projected growth trends, production technologies, key applications, and end-use industries.
Nutraceutical Gummies Segment by Company
Church & Dwight (CHD)
SCN BestCo
Amapharm
Sirio
Guangdong Yichao
Aland
Herbaland
Jinjiang Qifeng
TopGum
PharmaCare
Hero Nutritionals
Ningbo Jildan
Robinson Pharma
Catalent (Bettera Wellness)
UHA
Ernest Jackson
Procaps (Funtrition)
Cosmax
MeriCal
Makers Nutrition
NutraLab Corp
Domaco
ParkAcre
Nutra Solutions
VitaWest Nutraceuticals
Themis Medicare (LIN)
Jiangsu Handian
Nutraceutical Gummies Segment by Type
Starch Process
Starch-free Process
Nutraceutical Gummies Segment by Application
Vitamin Gummies
DHA and Omega-3 Gummies
Probiotics Gummies
Plant Extract Gummies
Other Gummies
Nutraceutical Gummies Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Nutraceutical Gummies status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Nutraceutical Gummies market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Nutraceutical Gummies significant trends, drivers, influence factors in global and regions.
6. To analyze Nutraceutical Gummies competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nutraceutical Gummies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nutraceutical Gummies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nutraceutical Gummies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Nutraceutical Gummies market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nutraceutical Gummies industry.
Chapter 3: Detailed analysis of Nutraceutical Gummies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Nutraceutical Gummies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Nutraceutical Gummies in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Starch Process
- Starch-free Process
Applications
- Vitamin Gummies
- DHA and Omega-3 Gummies
- Probiotics Gummies
- Plant Extract Gummies
- Other Gummies
Companies covered
- Church & Dwight (CHD)
- SCN BestCo
- Amapharm
- Sirio
- Guangdong Yichao
- Aland
- Herbaland
- Jinjiang Qifeng
- TopGum
- PharmaCare
- Hero Nutritionals
- Ningbo Jildan
- Robinson Pharma
- Catalent (Bettera Wellness)
- UHA
- Ernest Jackson
- Procaps (Funtrition)
- Cosmax
- MeriCal
- Makers Nutrition
- NutraLab Corp
- Domaco
- ParkAcre
- Nutra Solutions
- VitaWest Nutraceuticals
- Themis Medicare (LIN)
- Jiangsu Handian
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Nutraceutical Gummies Sales Value (2021-2032)
- 1.2.2 Global Nutraceutical Gummies Sales Volume (2021-2032)
- 1.2.3 Global Nutraceutical Gummies Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Nutraceutical Gummies Market Dynamics
- 2.1 Nutraceutical Gummies Industry Trends
- 2.2 Nutraceutical Gummies Industry Drivers
- 2.3 Nutraceutical Gummies Industry Opportunities and Challenges
- 2.4 Nutraceutical Gummies Industry Restraints
3 Nutraceutical Gummies Market by Company
- 3.1 Global Nutraceutical Gummies Company Revenue Ranking in 2025
- 3.2 Global Nutraceutical Gummies Revenue by Company (2021-2026)
- 3.3 Global Nutraceutical Gummies Sales Volume by Company (2021-2026)
- 3.4 Global Nutraceutical Gummies Average Price by Company (2021-2026)
- 3.5 Global Nutraceutical Gummies Company Ranking (2024-2026)
- 3.6 Global Nutraceutical Gummies Company Manufacturing Base and Headquarters
- 3.7 Global Nutraceutical Gummies Company Product Type and Application
- 3.8 Global Nutraceutical Gummies Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Nutraceutical Gummies Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Nutraceutical Gummies Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Nutraceutical Gummies Market by Type
- 4.1 Nutraceutical Gummies Type Introduction
- 4.1.1 Starch Process
- 4.1.2 Starch-free Process
- 4.2 Global Nutraceutical Gummies Sales Volume by Type
- 4.2.1 Global Nutraceutical Gummies Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Nutraceutical Gummies Sales Volume by Type (2021-2032)
- 4.2.3 Global Nutraceutical Gummies Sales Volume Share by Type (2021-2032)
- 4.3 Global Nutraceutical Gummies Sales Value by Type
- 4.3.1 Global Nutraceutical Gummies Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Nutraceutical Gummies Sales Value by Type (2021-2032)
- 4.3.3 Global Nutraceutical Gummies Sales Value Share by Type (2021-2032)
5 Nutraceutical Gummies Market by Application
- 5.1 Nutraceutical Gummies Application Introduction
- 5.1.1 Vitamin Gummies
- 5.1.2 DHA and Omega-3 Gummies
- 5.1.3 Probiotics Gummies
- 5.1.4 Plant Extract Gummies
- 5.1.5 Other Gummies
- 5.2 Global Nutraceutical Gummies Sales Volume by Application
- 5.2.1 Global Nutraceutical Gummies Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Nutraceutical Gummies Sales Volume by Application (2021-2032)
- 5.2.3 Global Nutraceutical Gummies Sales Volume Share by Application (2021-2032)
- 5.3 Global Nutraceutical Gummies Sales Value by Application
- 5.3.1 Global Nutraceutical Gummies Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Nutraceutical Gummies Sales Value by Application (2021-2032)
- 5.3.3 Global Nutraceutical Gummies Sales Value Share by Application (2021-2032)
6 Nutraceutical Gummies Regional Sales and Value Analysis
- 6.1 Global Nutraceutical Gummies Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Nutraceutical Gummies Sales by Region (2021-2032)
- 6.2.1 Global Nutraceutical Gummies Sales by Region: 2021-2026
- 6.2.2 Global Nutraceutical Gummies Sales by Region (2027-2032)
- 6.3 Global Nutraceutical Gummies Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Nutraceutical Gummies Sales Value by Region (2021-2032)
- 6.4.1 Global Nutraceutical Gummies Sales Value by Region: 2021-2026
- 6.4.2 Global Nutraceutical Gummies Sales Value by Region (2027-2032)
- 6.5 Global Nutraceutical Gummies Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Nutraceutical Gummies Sales Value (2021-2032)
- 6.6.2 North America Nutraceutical Gummies Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Nutraceutical Gummies Sales Value (2021-2032)
- 6.7.2 Europe Nutraceutical Gummies Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Nutraceutical Gummies Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Nutraceutical Gummies Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Nutraceutical Gummies Sales Value (2021-2032)
- 6.9.2 South America Nutraceutical Gummies Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Nutraceutical Gummies Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Nutraceutical Gummies Sales Value Share by Country, 2025 VS 2032
7 Nutraceutical Gummies Country-level Sales and Value Analysis
- 7.1 Global Nutraceutical Gummies Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Nutraceutical Gummies Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Nutraceutical Gummies Sales by Country (2021-2032)
- 7.3.1 Global Nutraceutical Gummies Sales by Country (2021-2026)
- 7.3.2 Global Nutraceutical Gummies Sales by Country (2027-2032)
- 7.4 Global Nutraceutical Gummies Sales Value by Country (2021-2032)
- 7.4.1 Global Nutraceutical Gummies Sales Value by Country (2021-2026)
- 7.4.2 Global Nutraceutical Gummies Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.9.2 France Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.16.2 China Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.19.2 India Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Nutraceutical Gummies Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Nutraceutical Gummies Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Nutraceutical Gummies Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Church & Dwight (CHD)
- 8.1.1 Church & Dwight (CHD) Company Information
- 8.1.2 Church & Dwight (CHD) Business Overview
- 8.1.3 Church & Dwight (CHD) Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Church & Dwight (CHD) Nutraceutical Gummies Product Portfolio
- 8.1.5 Church & Dwight (CHD) Recent Developments
- 8.2 SCN BestCo
- 8.2.1 SCN BestCo Company Information
- 8.2.2 SCN BestCo Business Overview
- 8.2.3 SCN BestCo Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.2.4 SCN BestCo Nutraceutical Gummies Product Portfolio
- 8.2.5 SCN BestCo Recent Developments
- 8.3 Amapharm
- 8.3.1 Amapharm Company Information
- 8.3.2 Amapharm Business Overview
- 8.3.3 Amapharm Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Amapharm Nutraceutical Gummies Product Portfolio
- 8.3.5 Amapharm Recent Developments
- 8.4 Sirio
- 8.4.1 Sirio Company Information
- 8.4.2 Sirio Business Overview
- 8.4.3 Sirio Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Sirio Nutraceutical Gummies Product Portfolio
- 8.4.5 Sirio Recent Developments
- 8.5 Guangdong Yichao
- 8.5.1 Guangdong Yichao Company Information
- 8.5.2 Guangdong Yichao Business Overview
- 8.5.3 Guangdong Yichao Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Guangdong Yichao Nutraceutical Gummies Product Portfolio
- 8.5.5 Guangdong Yichao Recent Developments
- 8.6 Aland
- 8.6.1 Aland Company Information
- 8.6.2 Aland Business Overview
- 8.6.3 Aland Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Aland Nutraceutical Gummies Product Portfolio
- 8.6.5 Aland Recent Developments
- 8.7 Herbaland
- 8.7.1 Herbaland Company Information
- 8.7.2 Herbaland Business Overview
- 8.7.3 Herbaland Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Herbaland Nutraceutical Gummies Product Portfolio
- 8.7.5 Herbaland Recent Developments
- 8.8 Jinjiang Qifeng
- 8.8.1 Jinjiang Qifeng Company Information
- 8.8.2 Jinjiang Qifeng Business Overview
- 8.8.3 Jinjiang Qifeng Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Jinjiang Qifeng Nutraceutical Gummies Product Portfolio
- 8.8.5 Jinjiang Qifeng Recent Developments
- 8.9 TopGum
- 8.9.1 TopGum Company Information
- 8.9.2 TopGum Business Overview
- 8.9.3 TopGum Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.9.4 TopGum Nutraceutical Gummies Product Portfolio
- 8.9.5 TopGum Recent Developments
- 8.10 PharmaCare
- 8.10.1 PharmaCare Company Information
- 8.10.2 PharmaCare Business Overview
- 8.10.3 PharmaCare Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.10.4 PharmaCare Nutraceutical Gummies Product Portfolio
- 8.10.5 PharmaCare Recent Developments
- 8.11 Hero Nutritionals
- 8.11.1 Hero Nutritionals Company Information
- 8.11.2 Hero Nutritionals Business Overview
- 8.11.3 Hero Nutritionals Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Hero Nutritionals Nutraceutical Gummies Product Portfolio
- 8.11.5 Hero Nutritionals Recent Developments
- 8.12 Ningbo Jildan
- 8.12.1 Ningbo Jildan Company Information
- 8.12.2 Ningbo Jildan Business Overview
- 8.12.3 Ningbo Jildan Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Ningbo Jildan Nutraceutical Gummies Product Portfolio
- 8.12.5 Ningbo Jildan Recent Developments
- 8.13 Robinson Pharma
- 8.13.1 Robinson Pharma Company Information
- 8.13.2 Robinson Pharma Business Overview
- 8.13.3 Robinson Pharma Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Robinson Pharma Nutraceutical Gummies Product Portfolio
- 8.13.5 Robinson Pharma Recent Developments
- 8.14 Catalent (Bettera Wellness)
- 8.14.1 Catalent (Bettera Wellness) Company Information
- 8.14.2 Catalent (Bettera Wellness) Business Overview
- 8.14.3 Catalent (Bettera Wellness) Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Catalent (Bettera Wellness) Nutraceutical Gummies Product Portfolio
- 8.14.5 Catalent (Bettera Wellness) Recent Developments
- 8.15 UHA
- 8.15.1 UHA Company Information
- 8.15.2 UHA Business Overview
- 8.15.3 UHA Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.15.4 UHA Nutraceutical Gummies Product Portfolio
- 8.15.5 UHA Recent Developments
- 8.16 Ernest Jackson
- 8.16.1 Ernest Jackson Company Information
- 8.16.2 Ernest Jackson Business Overview
- 8.16.3 Ernest Jackson Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Ernest Jackson Nutraceutical Gummies Product Portfolio
- 8.16.5 Ernest Jackson Recent Developments
- 8.17 Procaps (Funtrition)
- 8.17.1 Procaps (Funtrition) Company Information
- 8.17.2 Procaps (Funtrition) Business Overview
- 8.17.3 Procaps (Funtrition) Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Procaps (Funtrition) Nutraceutical Gummies Product Portfolio
- 8.17.5 Procaps (Funtrition) Recent Developments
- 8.18 Cosmax
- 8.18.1 Cosmax Company Information
- 8.18.2 Cosmax Business Overview
- 8.18.3 Cosmax Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.18.4 Cosmax Nutraceutical Gummies Product Portfolio
- 8.18.5 Cosmax Recent Developments
- 8.19 MeriCal
- 8.19.1 MeriCal Company Information
- 8.19.2 MeriCal Business Overview
- 8.19.3 MeriCal Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.19.4 MeriCal Nutraceutical Gummies Product Portfolio
- 8.19.5 MeriCal Recent Developments
- 8.20 Makers Nutrition
- 8.20.1 Makers Nutrition Company Information
- 8.20.2 Makers Nutrition Business Overview
- 8.20.3 Makers Nutrition Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.20.4 Makers Nutrition Nutraceutical Gummies Product Portfolio
- 8.20.5 Makers Nutrition Recent Developments
- 8.21 NutraLab Corp
- 8.21.1 NutraLab Corp Company Information
- 8.21.2 NutraLab Corp Business Overview
- 8.21.3 NutraLab Corp Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.21.4 NutraLab Corp Nutraceutical Gummies Product Portfolio
- 8.21.5 NutraLab Corp Recent Developments
- 8.22 Domaco
- 8.22.1 Domaco Company Information
- 8.22.2 Domaco Business Overview
- 8.22.3 Domaco Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.22.4 Domaco Nutraceutical Gummies Product Portfolio
- 8.22.5 Domaco Recent Developments
- 8.23 ParkAcre
- 8.23.1 ParkAcre Company Information
- 8.23.2 ParkAcre Business Overview
- 8.23.3 ParkAcre Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.23.4 ParkAcre Nutraceutical Gummies Product Portfolio
- 8.23.5 ParkAcre Recent Developments
- 8.24 Nutra Solutions
- 8.24.1 Nutra Solutions Company Information
- 8.24.2 Nutra Solutions Business Overview
- 8.24.3 Nutra Solutions Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.24.4 Nutra Solutions Nutraceutical Gummies Product Portfolio
- 8.24.5 Nutra Solutions Recent Developments
- 8.25 VitaWest Nutraceuticals
- 8.25.1 VitaWest Nutraceuticals Company Information
- 8.25.2 VitaWest Nutraceuticals Business Overview
- 8.25.3 VitaWest Nutraceuticals Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.25.4 VitaWest Nutraceuticals Nutraceutical Gummies Product Portfolio
- 8.25.5 VitaWest Nutraceuticals Recent Developments
- 8.26 Themis Medicare (LIN)
- 8.26.1 Themis Medicare (LIN) Company Information
- 8.26.2 Themis Medicare (LIN) Business Overview
- 8.26.3 Themis Medicare (LIN) Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.26.4 Themis Medicare (LIN) Nutraceutical Gummies Product Portfolio
- 8.26.5 Themis Medicare (LIN) Recent Developments
- 8.27 Jiangsu Handian
- 8.27.1 Jiangsu Handian Company Information
- 8.27.2 Jiangsu Handian Business Overview
- 8.27.3 Jiangsu Handian Nutraceutical Gummies Sales, Value and Gross Margin (2021-2026)
- 8.27.4 Jiangsu Handian Nutraceutical Gummies Product Portfolio
- 8.27.5 Jiangsu Handian Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Nutraceutical Gummies Value Chain Analysis
- 9.1.1 Nutraceutical Gummies Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Nutraceutical Gummies Sales Mode & Process
- 9.2 Nutraceutical Gummies Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Nutraceutical Gummies Distributors
- 9.2.3 Nutraceutical Gummies Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst